Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection (ACTIV4)

NCT05226416 is registered in ClinicalTrials.gov with Eurasian Association of Therapists as lead sponsor.

NCT NCT05226416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05226416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Analysis of Health Status of Сomorbid Adult Patients With COVID-19 Hospitalised in Fourth Wave of SARS-CoV-2 Infection (ACTIV4)
Lead sponsor
Eurasian Association of Therapists
Phase
Observational
Overall status
Completed
Start date
February 21, 2022
Completion date
April 21, 2023
Enrollment
3,554 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, arrythmia, asthma, atrial fibrillation, chronic heart failure, chronic kidney diseases, copd, covid-19, diabetes mellitus, dvt, hypertensive heart disease, ischemic heart disease, ischemic stroke, myocardial infarction, myocarditis, oncology, overweight and obesity, pulmonary embolism, stroke